首页 > 最新文献

Medecine & Droit最新文献

英文 中文
De la fondation pour l’évaluation des techniques et pratiques médicales à la Haute Autorité de santé : l’évolution institutionnelle de l’évaluation des actes et des produits de santé 从医疗技术和实践评估基金会到卫生高级当局:卫生行为和卫生产品评估的体制演变
IF 0.1 Q4 MEDICINE, LEGAL Pub Date : 2025-08-01 DOI: 10.1016/j.meddro.2024.11.001
Isabelle Poirot Mazères (Professeur de droit public, Présidente de l’Association française de droit de la santé, Présidente du collège de déontologie du CHU de Toulouse)
If the evaluation of the quality of health procedures and products as well as the measurement of the relevance of reimbursement by health insurance are constituent dimensions of the health system, they have only been acquired at the end of an evolution which has seen the gradual erasure of medical power and the parallel affirmation of expertise other than clinical, particularly medico-economic. Since 1986, several institutions responsible for evaluation have succeeded one another, with different statuses and increasingly broad missions, from the evaluation of professional acts or the formulation of clinical practices guidelines to the certification of health establishments, social and medico social. It is currently the High Health Authority which assumes this central role through which it contributes in this area of evaluation and standardization, to “the regulation of the health system through quality and efficiency”.
如果对卫生程序和产品质量的评估以及对医疗保险报销相关性的衡量是卫生系统的组成部分,那么它们只是在一场演变的最后才获得的,这场演变见证了医疗权力的逐渐消除,以及对临床以外的专业知识的平行肯定,特别是医学经济学。自1986年以来,几个负责评价的机构相互接替,地位不同,任务越来越广泛,从评价专业行为或制定临床实践准则到对保健机构、社会和社会医疗机构进行认证。目前由高级卫生当局承担这一核心作用,通过它在这一评估和标准化领域作出贡献,以“通过质量和效率调节卫生系统”。
{"title":"De la fondation pour l’évaluation des techniques et pratiques médicales à la Haute Autorité de santé : l’évolution institutionnelle de l’évaluation des actes et des produits de santé","authors":"Isabelle Poirot Mazères (Professeur de droit public, Présidente de l’Association française de droit de la santé, Présidente du collège de déontologie du CHU de Toulouse)","doi":"10.1016/j.meddro.2024.11.001","DOIUrl":"10.1016/j.meddro.2024.11.001","url":null,"abstract":"<div><div>If the evaluation of the quality of health procedures and products as well as the measurement of the relevance of reimbursement by health insurance are constituent dimensions of the health system, they have only been acquired at the end of an evolution which has seen the gradual erasure of medical power and the parallel affirmation of expertise other than clinical, particularly medico-economic. Since 1986, several institutions responsible for evaluation have succeeded one another, with different statuses and increasingly broad missions, from the evaluation of professional acts or the formulation of clinical practices guidelines to the certification of health establishments, social and medico social. It is currently the High Health Authority which assumes this central role through which it contributes in this area of evaluation and standardization, to “the regulation of the health system through quality and efficiency”.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2025 193","pages":"Pages 101-105"},"PeriodicalIF":0.1,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144890645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L’inceste, je te crois, je te soutiens 乱伦我相信你,我支持你
IF 0.1 Q4 MEDICINE, LEGAL Pub Date : 2025-06-01 DOI: 10.1016/j.meddro.2024.12.004
Jacqueline Castany (Médecin)
{"title":"L’inceste, je te crois, je te soutiens","authors":"Jacqueline Castany (Médecin)","doi":"10.1016/j.meddro.2024.12.004","DOIUrl":"10.1016/j.meddro.2024.12.004","url":null,"abstract":"","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2025 192","pages":"Pages 63-64"},"PeriodicalIF":0.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144240769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Réflexions sur les métamorphoses de la fin de vie 思考生命终结的变形
IF 0.1 Q4 MEDICINE, LEGAL Pub Date : 2025-06-01 DOI: 10.1016/j.meddro.2025.03.001
François Vialla
As Parliament prepares to legislate on end-of-life issues, the author draws on philosophy and literature to shed light on a societal debate that extends far beyond the realm of medicine.
随着议会准备就临终问题立法,作者利用哲学和文学来阐明一场远远超出医学领域的社会辩论。
{"title":"Réflexions sur les métamorphoses de la fin de vie","authors":"François Vialla","doi":"10.1016/j.meddro.2025.03.001","DOIUrl":"10.1016/j.meddro.2025.03.001","url":null,"abstract":"<div><div>As Parliament prepares to legislate on end-of-life issues, the author draws on philosophy and literature to shed light on a societal debate that extends far beyond the realm of medicine.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2025 192","pages":"Pages 65-74"},"PeriodicalIF":0.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144240770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L’application de l’article 223-1 du Code pénal en santé 《刑法》第223-1条在健康方面的适用情况
IF 0.1 Q4 MEDICINE, LEGAL Pub Date : 2025-06-01 DOI: 10.1016/j.meddro.2024.12.003
Caroline Lacroix (Maître de Conférences HDR)
The offence of causing risks to others was one of the major innovations of the Penal Code that came into force in 1994. According to article 223-1 of the Penal Code, the act of directly exposing others to an immediate risk of death or injury likely to result in mutilation or permanent disability through a manifestly deliberate violation of a particular obligation of prudence or safety imposed by law or regulation is punishable by one year of imprisonment and a fine of 15,000 euros. Thirty years of application of the offence provide an opportunity to question the application of the offence of causing risks to others in the field of health. The study of case law reveals that health is resistant to criminalization. Only limited hypotheses are likely to fall under the scope of criminal repression. Faced with this observation, the idea of a legislative evolution of the criminalization of endangerment, particularly in health, has been put forward. Should we then rethink repression and to what extent?
对他人造成危险的罪行是1994年生效的《刑法》的主要创新之一。根据《刑法》第223-1条,明显故意违反法律或法规规定的特定审慎或安全义务,直接使他人面临可能导致致残或永久残疾的死亡或受伤的直接危险的行为,可处以一年监禁和15 000欧元罚款。适用这一罪行已有三十年,这为质疑在健康领域对他人造成危险这一罪行的适用提供了机会。判例法的研究表明,健康是抗拒刑事定罪的。只有有限的假设可能属于刑事压制的范围。面对这一观察结果,有人提出了立法上逐步将危害,特别是在健康方面危害定为刑事犯罪的想法。那么,我们是否应该重新思考压迫,以及在何种程度上?
{"title":"L’application de l’article 223-1 du Code pénal en santé","authors":"Caroline Lacroix (Maître de Conférences HDR)","doi":"10.1016/j.meddro.2024.12.003","DOIUrl":"10.1016/j.meddro.2024.12.003","url":null,"abstract":"<div><div>The offence of causing risks to others was one of the major innovations of the Penal Code that came into force in 1994. According to article 223-1 of the Penal Code, the act of directly exposing others to an immediate risk of death or injury likely to result in mutilation or permanent disability through a manifestly deliberate violation of a particular obligation of prudence or safety imposed by law or regulation is punishable by one year of imprisonment and a fine of 15,000 euros. Thirty years of application of the offence provide an opportunity to question the application of the offence of causing risks to others in the field of health. The study of case law reveals that health is resistant to criminalization. Only limited hypotheses are likely to fall under the scope of criminal repression. Faced with this observation, the idea of a legislative evolution of the criminalization of endangerment, particularly in health, has been put forward. Should we then rethink repression and to what extent?</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2025 192","pages":"Pages 75-80"},"PeriodicalIF":0.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144240771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La Haute Autorité de santé, un acteur du développement des droits des usagers ? 卫生高级当局,在发展使用者权利方面发挥作用?
IF 0.1 Q4 MEDICINE, LEGAL Pub Date : 2025-06-01 DOI: 10.1016/j.meddro.2024.11.002
Marion Girer (Professeure des Universités en droit)
The Health High Authority has produced numerous publications on users’ rights, which we will analyse to see whether they contribute to the development of these rights. The first area is respect for fundamental human rights. In the healthcare sector, this mainly concerns dignity, privacy and confidentiality, freedom of movement and the promotion of good treatment: the HAS deals with almost all the fundamental rights recognised to patients, making it possible to check, at least in theory, that these rights are respected during care. In the medico-social and social sector, the fundamental rights of users are satisfactorily taken into account, but the wording is sometimes vague and abstract, which could prevent these rights from being applied in practice. The second priority is to make users real players in their own care. In the healthcare sector, the HAS has drawn up a detailed overview of rights, with patient information, involvement and consent occupying a central place. In the medico-social and social sector, the HAS promotes the empowerment of supported persons, in particular through the involvement of users in the construction of their support project. The HAS appears to be more of a player in disseminating knowledge of rights, and will have to take care to erase the impression of a ‘catalogue’ of rights by referring to values and ethical principles.
卫生高级管理局出版了许多关于使用者权利的出版物,我们将对这些出版物进行分析,看它们是否有助于这些权利的发展。第一个领域是尊重基本人权。在保健部门,这主要涉及尊严、隐私和保密、行动自由和促进良好治疗:《保健制度》涉及几乎所有公认的病人基本权利,至少在理论上可以检查这些权利在护理期间是否得到尊重。在医疗-社会和社会部门,用户的基本权利得到了令人满意的考虑,但措词有时含糊和抽象,这可能妨碍这些权利在实践中得到应用。第二个优先事项是让用户真正成为自己关心的玩家。在医疗保健部门,卫生管理局起草了一份详细的权利概述,以病人的信息、参与和同意为中心。在医疗-社会和社会部门,保健服务促进被支助者的赋权,特别是通过让使用者参与其支助项目的建设。在传播权利知识方面,民政事务局似乎更像是一个参与者,必须注意通过提及价值观和道德原则来消除对权利“目录”的印象。
{"title":"La Haute Autorité de santé, un acteur du développement des droits des usagers ?","authors":"Marion Girer (Professeure des Universités en droit)","doi":"10.1016/j.meddro.2024.11.002","DOIUrl":"10.1016/j.meddro.2024.11.002","url":null,"abstract":"<div><div>The Health High Authority has produced numerous publications on users’ rights, which we will analyse to see whether they contribute to the development of these rights. The first area is respect for fundamental human rights. In the healthcare sector, this mainly concerns dignity, privacy and confidentiality, freedom of movement and the promotion of good treatment: the HAS deals with almost all the fundamental rights recognised to patients, making it possible to check, at least in theory, that these rights are respected during care. In the medico-social and social sector, the fundamental rights of users are satisfactorily taken into account, but the wording is sometimes vague and abstract, which could prevent these rights from being applied in practice. The second priority is to make users real players in their own care. In the healthcare sector, the HAS has drawn up a detailed overview of rights, with patient information, involvement and consent occupying a central place. In the medico-social and social sector, the HAS promotes the empowerment of supported persons, in particular through the involvement of users in the construction of their support project. The HAS appears to be more of a player in disseminating knowledge of rights, and will have to take care to erase the impression of a ‘catalogue’ of rights by referring to values and ethical principles.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2025 192","pages":"Pages 81-84"},"PeriodicalIF":0.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144240772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Les ressorts de l’autorité de la HAS : indépendance et expertise HAS的职权范围:独立性和专门知识
IF 0.1 Q4 MEDICINE, LEGAL Pub Date : 2025-06-01 DOI: 10.1016/j.meddro.2024.12.002
Paul Véron (Maître de conférences en droit)
As an independent public authority with scientific status, the French Haute Autorité de santé does not have regulatory powers. It mainly provides recommendations or opinions, which are soft law standards. Its authority is therefore based above all on the compliance of the recipients of these standards, which can only be achieved on a dual condition: the probity of the experts and the quality of the expertise.
法国高等自治机构(Haute autorit de sant)作为具有科学地位的独立公共机构,并不具有监管权力。它主要提供建议或意见,这是软法律标准。因此,它的权威首先取决于这些标准的接受者是否遵守这些标准,而这些标准只有在双重条件下才能实现:专家的正直和专业知识的质量。
{"title":"Les ressorts de l’autorité de la HAS : indépendance et expertise","authors":"Paul Véron (Maître de conférences en droit)","doi":"10.1016/j.meddro.2024.12.002","DOIUrl":"10.1016/j.meddro.2024.12.002","url":null,"abstract":"<div><div>As an independent public authority with scientific status, the French Haute Autorité de santé does not have regulatory powers. It mainly provides recommendations or opinions, which are soft law standards. Its authority is therefore based above all on the compliance of the recipients of these standards, which can only be achieved on a dual condition: the probity of the experts and the quality of the expertise.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2025 192","pages":"Pages 85-88"},"PeriodicalIF":0.1,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144240773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La Haute Autorité de santé et la participation des usagers aux instances institutionnelles 卫生高级当局和使用者参与机构机构
IF 0.1 Q4 MEDICINE, LEGAL Pub Date : 2025-04-01 DOI: 10.1016/j.meddro.2025.01.008
Stéphanie Rabiller (Maître de conférences, HDR)
The active participation of users in the healthcare system, although widely proclaimed, is struggling to be fully in practice. Despite the 2002 laws instituting bodies such as the CDU such as the CDU and CVS, there are still obstacles to involving people in decision-making. The HAS, which is endeavouring to improve this situation by activating a number of levers, will have to ensure that it goes beyond organisational issues to make the right to participation a concrete and effective reality, a real issue of political freedom and citizenship.
用户在医疗保健系统的积极参与,虽然广泛宣布,是努力在实践中充分。尽管2002年的法律设立了像基民盟和CVS这样的机构,但让人民参与决策仍然存在障碍。行政当局正在努力通过激活若干手段来改善这种情况,它必须确保它超越组织问题,使参与权利成为具体和有效的现实,成为政治自由和公民身份的真正问题。
{"title":"La Haute Autorité de santé et la participation des usagers aux instances institutionnelles","authors":"Stéphanie Rabiller (Maître de conférences, HDR)","doi":"10.1016/j.meddro.2025.01.008","DOIUrl":"10.1016/j.meddro.2025.01.008","url":null,"abstract":"<div><div>The active participation of users in the healthcare system, although widely proclaimed, is struggling to be fully in practice. Despite the 2002 laws instituting bodies such as the CDU such as the CDU and CVS, there are still obstacles to involving people in decision-making. The HAS, which is endeavouring to improve this situation by activating a number of levers, will have to ensure that it goes beyond organisational issues to make the right to participation a concrete and effective reality, a real issue of political freedom and citizenship.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2025 191","pages":"Pages 37-41"},"PeriodicalIF":0.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143738380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Déprescription et responsabilité médicale 处方和医疗责任
IF 0.1 Q4 MEDICINE, LEGAL Pub Date : 2025-04-01 DOI: 10.1016/j.meddro.2024.09.001
Francis Megerlin , Gilles Bouvenot , Patrice Queneau
Deprescribing aim to improve the clinical condition of patients, through progressively reducing and/or discontinuing certain drug treatments. This paper reports its conceptual genesis and gradual diffusion, the dynamics of practitioners/healthcare insurer agreements in France, and medical liability. Irrespective of any incentive agreement, consideration of the advisability of de-prescribing has become mandatory in situations where iatrogenic risks are well established – particularly in the case of multi-medication treatments: as knowledge grows, failure to deprescribe (or to consider the advisability of doing so) could be considered a fault. However, de-prescribing is not a quantitative approach, due to its clinical purpose and consequences: it requires gathering scattered data, prioritizing treatments, planning, and sometimes arbitrating between therapeutic intentions. Interprofessional collaboration is then served by new tools and informed by experience-sharing: they alone can meet the clinical and societal challenge of deprescribing, while dedicated algorithms and AI are coming.
开处方的目的是通过逐步减少和/或停止某些药物治疗来改善患者的临床状况。本文报告其概念的起源和逐渐扩散,从业者/医疗保险协议在法国的动态,和医疗责任。无论是否有任何激励协议,在医源性风险已经确定的情况下,特别是在多种药物治疗的情况下,考虑取消处方的可取性已经成为强制性的:随着知识的增长,未能取消处方(或考虑这样做的可取性)可能被视为过失。然而,由于其临床目的和后果,取消处方并不是一种定量方法:它需要收集分散的数据,确定治疗的优先顺序,制定计划,有时还需要在治疗意图之间进行仲裁。然后,新工具为跨专业合作提供了服务,并通过经验分享提供了信息:仅凭它们就可以应对处方的临床和社会挑战,而专用算法和人工智能即将到来。
{"title":"Déprescription et responsabilité médicale","authors":"Francis Megerlin ,&nbsp;Gilles Bouvenot ,&nbsp;Patrice Queneau","doi":"10.1016/j.meddro.2024.09.001","DOIUrl":"10.1016/j.meddro.2024.09.001","url":null,"abstract":"<div><div>Deprescribing aim to improve the clinical condition of patients, through progressively reducing and/or discontinuing certain drug treatments. This paper reports its conceptual genesis and gradual diffusion, the dynamics of practitioners/healthcare insurer agreements in France, and medical liability. Irrespective of any incentive agreement, consideration of the advisability of de-prescribing has become mandatory in situations where iatrogenic risks are well established – particularly in the case of multi-medication treatments: as knowledge grows, failure to deprescribe (or to consider the advisability of doing so) could be considered a fault. However, de-prescribing is not a quantitative approach, due to its clinical purpose and consequences: it requires gathering scattered data, prioritizing treatments, planning, and sometimes arbitrating between therapeutic intentions. Interprofessional collaboration is then served by new tools and informed by experience-sharing: they alone can meet the clinical and societal challenge of deprescribing, while dedicated algorithms and AI are coming.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2025 191","pages":"Pages 46-52"},"PeriodicalIF":0.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143738382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repenser la prise en charge de la santé mentale à l’ère de l’IA 在人工智能时代重新思考心理健康
IF 0.1 Q4 MEDICINE, LEGAL Pub Date : 2025-04-01 DOI: 10.1016/j.meddro.2024.10.003
Amandine Cayol (Maître de conférences en droit privé, Codirectrice du Master Droit des assurances, Codirectrice de la Clinique juridique de Normandie, Membre de l’Institut Caennais de Recherche Juridique – ICReJ (UR 967), Membre associée du LexFEIM, Le Havre (UR 1013))
The growing use of artificial intelligence systems in the field of mental health is not without consequences for patient care and the medical relationship. It influences both the role of the doctor and the place of the patient.
人工智能系统在心理健康领域的应用越来越多,这对患者护理和医疗关系并非没有影响。它既影响医生的角色,也影响病人的地位。
{"title":"Repenser la prise en charge de la santé mentale à l’ère de l’IA","authors":"Amandine Cayol (Maître de conférences en droit privé, Codirectrice du Master Droit des assurances, Codirectrice de la Clinique juridique de Normandie, Membre de l’Institut Caennais de Recherche Juridique – ICReJ (UR 967), Membre associée du LexFEIM, Le Havre (UR 1013))","doi":"10.1016/j.meddro.2024.10.003","DOIUrl":"10.1016/j.meddro.2024.10.003","url":null,"abstract":"<div><div>The growing use of artificial intelligence systems in the field of mental health is not without consequences for patient care and the medical relationship. It influences both the role of the doctor and the place of the patient.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2025 191","pages":"Pages 53-55"},"PeriodicalIF":0.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143738383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stratégie et certification des établissements de santé 卫生保健机构的战略和认证
IF 0.1 Q4 MEDICINE, LEGAL Pub Date : 2025-04-01 DOI: 10.1016/j.meddro.2024.11.004
Arnaud Lami (Maître de conférences HDR)
Established for several decades, the certification of healthcare establishments has continued to grow. Having become an essential element of healthcare system governance, certification has led to many innovations. As a result, healthcare establishments have had to develop strategies to best appropriate this approach.
经过几十年的发展,医疗机构的认证一直在增长。认证已成为医疗保健系统治理的基本要素,并带来了许多创新。因此,医疗机构必须制定最适合这种方法的战略。
{"title":"Stratégie et certification des établissements de santé","authors":"Arnaud Lami (Maître de conférences HDR)","doi":"10.1016/j.meddro.2024.11.004","DOIUrl":"10.1016/j.meddro.2024.11.004","url":null,"abstract":"<div><div>Established for several decades, the certification of healthcare establishments has continued to grow. Having become an essential element of healthcare system governance, certification has led to many innovations. As a result, healthcare establishments have had to develop strategies to best appropriate this approach.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2025 191","pages":"Pages 42-45"},"PeriodicalIF":0.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143738381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medecine & Droit
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1